The European neurostimulation device market is growing modestly, and will be buoyed over the forecast period by the ongoing launch of premium-priced products. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for neurostimulation devices in France, Germany, Italy, Spain and the UK across a 10-year period.


What are the major growth areas driving the European neurostimulation market?

How much growth will be experienced by more mature segments such as SCS?

How will new technologies affect the SCS, DBS, SNS and VNS markets?

What indications are approved for neurostimulation therapy in Europe vs. the US?

What additional patient populations are treated with neurostimulation devices in Europe?

Will new indications arise over the forecast period?

Table of contents

  • Europe
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Factors and Developments
      • End-User Insights
      • Geographies Covered
      • Products Covered
    • Version History
    • Neurostimulation Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Competitive Landscape
      • Market Shares
      • Market Factors and Developments
    • Spinal Cord Stimulation Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
    • Deep Brain Stimulation Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Parkinson's Disease
        • Essential Tremor
        • Epilepsy
        • Dystonia
        • Obsessive Compulsive Disorder
      • Competitive Highlights
      • Market Shares
    • Sacral Nerve Stimulation Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Overactive Bladder
        • Fecal Incontinence
      • Competitive Highlights
      • Market Shares
    • Vagus Nerve Stimulation Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Epilepsy
        • Major Depressive Disorder
        • Obesity
      • Competitive Highlights
      • Market Shares
    • Gastric Electric Stimulation Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Michael Tian, PhD

Michael Tian is a senior analyst within the Cardiovascular Medtech Insights team at Decision Resources Group and is an expert in interventional cardiology, cardiac surgery, vascular access, and interventional oncology device markets. Michael spends much of his time exploring and translating large claims and hospital purchase datasets into intriguing stories within the global MedTech market, and he is always looking for the next challenging question to tackle. Michael holds a in Physiology and Neuroscience from the University of Toronto.


Related Reports

Neurostimulation Devices | Medtech 360 | Market Insights | United States

The US neurostimulation device market will grow rapidly through 2027, driven by expanding approval of these devices for new indications, increasing demand for non-pha...

View Details

Neurostimulation Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European neurostimulation device market is growing modestly, and will be buoyed over the forecast period by the ongoing launch of premium-priced products.  This Medtech 360 Re...

View Details